• Home
  • About BCHT
    • Our company
    • Development History
    • Enterprise Idea
    • Honors
    • Subsidiary
    • Social Responsibility
    • Company Display
  • Media
    • BCHT News
  • R&D
    • R&D conditions
    • Technology platform
    • Scientific research cooperation
  • Products
    • Listed products
  • Investors
    • Subscribe
    • Corporate Calendar
    • Financial Reports
    • Ad Hoc Announcements
    • GDR Related Information
    • Other Information
  • Contact Us
    • Contact way

Hotline:

400-8845-777
Media

  • BCHT News
  • 12
    2022-01
    BCHT IPO

    On June 25, 2021, Changchun BCHT Biotechnology Co., made an initial public offering (IPO) and was listed on the Science and Technology Innov

  • 01
    2021-03
    The Mayor of Changchun Visit Changchun BCHT

    On February 25, 2021, Zhang Zhijun, Deputy Secretary of Changchun Municipal Committee of the CPC and Mayor of Changchun, and his delegation

  • 04
    2020-03
    First Nasal Spray Influenza Vaccine Launch to the Domesti...

    On 25 Feb.,2021, Influenza Vaccine, Live, Nasal, Freeze-dried produced by Changchun BCHT Biotechnology Co. (BCHT) has been approved by the N

1260 Huoju Road, Changchun High-tech Zone, Changchun, Jilin, China

400-8845-777

bcht@hdjx666.com

Stock Code：688276

  • Home
  • About BCHT
  • Media
  • R&D
  • Products
  • Investors
  • Contact Us

©Changchun BCHT Biotechnology Co. Ji ICP reserve 19006152 Statement: If the content of the website involves infringement, please contact us in time to deal with. Contact number: 0431-81871520

Scan Us
Learn More